Invention Grant
- Patent Title: Heterocyclic carboxylic acid ester derivative
- Patent Title (中): 杂环羧酸酯衍生物
-
Application No.: US14098774Application Date: 2013-12-06
-
Publication No.: US09346821B2Publication Date: 2016-05-24
- Inventor: Tamotsu Suzuki , Takahiro Koshiba , Munetaka Tokumasu , Koji Ohsumi
- Applicant: AJINOMOTO CO., INC.
- Applicant Address: JP Tokyo
- Assignee: AJINOMOTO CO., INC.
- Current Assignee: AJINOMOTO CO., INC.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2011-127700 20110607
- Main IPC: C07D495/04
- IPC: C07D495/04 ; C07D307/68 ; C07D333/38 ; C07D405/06 ; C07D409/06 ; C07D417/06 ; A61K38/00
Abstract:
The present invention provides a blood glucose elevation inhibitor having a serine protease inhibitory action, which is a novel therapeutic or prophylactic agent for obesity. A compound represented by the following formula (I) wherein each symbol is as described in the specification, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20140094489A1 HETEROCYCLIC CARBOXYLIC ACID ESTER DERIVATIVE Public/Granted day:2014-04-03
Information query
